BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11252592)

  • 1. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests.
    Dendukuri N; Joseph L
    Biometrics; 2001 Mar; 57(1):158-67. PubMed ID: 11252592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating disease prevalence in the absence of a gold standard.
    Black MA; Craig BA
    Stat Med; 2002 Sep; 21(18):2653-69. PubMed ID: 12228883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard.
    Joseph L; Gyorkos TW; Coupal L
    Am J Epidemiol; 1995 Feb; 141(3):263-72. PubMed ID: 7840100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian sample-size determination for inference on two binomial populations with no gold standard classifier.
    Stamey JD; Seaman JW; Young DM
    Stat Med; 2005 Oct; 24(19):2963-76. PubMed ID: 16007574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test.
    Dendukuri N; Rahme E; Bélisle P; Joseph L
    Biometrics; 2004 Jun; 60(2):388-97. PubMed ID: 15180664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian sample size for diagnostic test studies in the absence of a gold standard: Comparing identifiable with non-identifiable models.
    Dendukuri N; Bélisle P; Joseph L
    Stat Med; 2010 Nov; 29(26):2688-97. PubMed ID: 20803558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling conditional dependence among multiple diagnostic tests.
    Wang Z; Dendukuri N; Zar HJ; Joseph L
    Stat Med; 2017 Dec; 36(30):4843-4859. PubMed ID: 28875512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian latent class models with conditionally dependent diagnostic tests: a case study.
    Menten J; Boelaert M; Lesaffre E
    Stat Med; 2008 Sep; 27(22):4469-88. PubMed ID: 18551515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inference on cancer screening exam accuracy using population-level administrative data.
    Jiang H; Brown PE; Walter SD
    Stat Med; 2016 Jan; 35(1):130-46. PubMed ID: 26278587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating sensitivity and specificity of diagnostic tests using latent class models that account for conditional dependence between tests: a simulation study.
    Keddie SH; Baerenbold O; Keogh RH; Bradley J
    BMC Med Res Methodol; 2023 Mar; 23(1):58. PubMed ID: 36894883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian semiparametric approach to correlated ROC surfaces with stochastic order constraints.
    Chen Z; Hwang BS
    Biometrics; 2019 Jun; 75(2):539-550. PubMed ID: 30390405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A probit latent class model with general correlation structures for evaluating accuracy of diagnostic tests.
    Xu H; Craig BA
    Biometrics; 2009 Dec; 65(4):1145-55. PubMed ID: 19210729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling conditional dependence between diagnostic tests: a multiple latent variable model.
    Dendukuri N; Hadgu A; Wang L
    Stat Med; 2009 Feb; 28(3):441-61. PubMed ID: 19067379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian approach to model the conditional correlation between several diagnostic tests and various replicated subjects measurements.
    Pereira da Silva HD; Ascaso C; Gonçalves AQ; Orlandi PP; Abellana R
    Stat Med; 2017 Sep; 36(20):3154-3170. PubMed ID: 28543307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of prior information and stratification for parameter estimation with two screening tests but no gold standard.
    Gustafson P
    Stat Med; 2005 Apr; 24(8):1203-17. PubMed ID: 15558709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian estimation of intervention effect with pre- and post-misclassified binomial data.
    Stamey JD; Seaman JW; Young DM
    J Biopharm Stat; 2007; 17(1):93-108. PubMed ID: 17219757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian inference for kappa from single and multiple studies.
    Basu S; Banerjee M; Sen A
    Biometrics; 2000 Jun; 56(2):577-82. PubMed ID: 10877319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Two Bayesian Methods in Evaluation of the Absence of the Gold Standard Diagnostic Tests.
    Li T; Liu P
    Biomed Res Int; 2019; 2019():1374748. PubMed ID: 31531344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian inference for recurrent events data using time-dependent frailty.
    Manda SO; Meyer R
    Stat Med; 2005 Apr; 24(8):1263-74. PubMed ID: 15568192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible Bayesian quantile regression for independent and clustered data.
    Reich BJ; Bondell HD; Wang HJ
    Biostatistics; 2010 Apr; 11(2):337-52. PubMed ID: 19948746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.